Arpeggio Bio
Boulder
About Arpeggio Bio
Arpeggio Biosciences leverages state of the art sequencing approaches coupled with powerful machine learning to uncover novel insights into a compound's biological mechanism of action. The company is diverse set of molecular biologists, computer scientists, and biotechnology enthusiasts passionate about understanding where, why, and how therapeutics work.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $40.4M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2025)
- Website: arpeggiobio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Machine Learning, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/arpeggio-bio-75593 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.